Pirtobrutinib (Jaypirca)
Indications
Mantle Cell Lymphoma (see Lymphoma)
Clinical Efficacy
Pharmacology
Bruton’s Tyrosine Kinase (BTK) Inhibitor
- Inhibits B-Cell Lymphocyte Proliferation and Survival
Metabolism
Administration
Oral (PO)
Dose Adjustment
Use in Pregnancy (see Pregnancy)
Use During Breast Feeding
Adverse Effects
Pulmonary Adverse Effects
Cough (see Cough)
Pneumonia (see xxxx)
References